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ABSTRACT 
A  series  of  2-phenyl-1,3-benzoxazoles  were  synthesized  by  the  reaction  of  2-aminophenol  and  acyl  chlorides  using    microwave  irradiation.    Purity  of 
compounds was determined  by TLC.  All the  synthesized compounds  were characterized by spectral analysis (FTIR, 
1H-NMR ). The compounds  were 
evaluated for in vitro antimicrobial activity against  Bacillus pumilus, Bacillus subtilis (Gram  positive); Escherichia coli, Pseudomonas aeruginosa (Gram  
negative) and Candida albicans and  Aspergillus niger by agar-well diffusion method at 2.5, 5, 10mg/ml. Compounds 2-(2-methoxyphenyl)-1,3-benzoxazole, 
2-(4-bromophenyl)-1,3-benzoxazole,  2-(3-cholorophenyl)-1,3-benzoxazole,  2-(2-nitrophenyl)-1,3-benzoxazole  have  been  found  to  have  good  antibacterial 
activity. Compounds 2-pheny-1,3-benzoxazole, 2-(4-bromophenyl)-1,3-benzoxazole, were potent antifungal compounds amongst the series. 
Keywords: Benzoxazoles, Microwave irradiation, Antimicrobial activity. 
 
INTRODUCTION 
The  widespread  use  of  antibiotics  has  resulted  in  the 
emergence  of  antibiotic-resistant  organisms.  Not  only  is 
antibiotic resistance on the rise, but emerging pathogens are 
seen  in  ever-growing  populations.  Newly  identified 
pathogens  are  resistant  to  a  broader  panel  of  drugs  and 
sometimes to entire classes of antibiotic agents.  
Various nuclei have been explored for antimicrobial activity 
viz.  benzothiazepine
1,  triazole
2,indazole
3,  quinazoline
4, 
pyrazole
5, imidazole
6, benzimidazole
7, benzoxazole
8. During 
recent years there have been some interesting developments 
in the biological activities of benzoxazole derivatives. These 
compounds have special significance in the field of medicinal 
chemistry  due  to  their  remarkable  pharmacological 
potentialities.  Benzoxazole  nucleus  have  been  reported 
various types of biological activities such as Antidepressant, 
Antibacterial, Antifungal, Anti-inflammatory, Analgesic and 
Anticancer.
9  
Two commonly used approaches for the construction of the 
benzoxazole ring system are: the first approach involves the 
coupling  of  the  2-aminophenols  with  carboxylic  acid 
derivatives under strongly acidic conditions at high reaction 
temperatures
10 while the second approach uses the reaction of 
2-aminophenols  with  an  aldehyde  via  the  oxidative 
cyclization  of  imine  intermediates
11.  Microwave  induced 
organic  reaction  chemistry 
12,  13  is  becoming  popular  and 
considered as  a  step towards  green  chemistry.  The  present 
work  aimed  to  synthesize  a    series  of    2  –phenyl-1,3- 
benzoxazoles  derivatives  in  order  to  determine  their 
antimicrobial activities. 
In  this  communication,  results  of  synthesis,  spectroscopic 
studies and antimicrobial activity of substituted 2-phenyl-1, 
3-benzoxazole derivatives are presented. 
MATERIALS AND METHODS 
All  the  chemicals  used  for  the  study  were  obtained  from 
Sigma  Aldrich  and  LOBA-e.  For  synthesis,  microwave 
synthesizer  CEM-Labmet  was  used.  The  melting  points  of 
compounds  were  determined  using  Visual  Melting  Point 
Apparatus (Lab India MR-VIS). The progress of the reaction 
was monitored by Thin Layer Chromatographic technique by 
using glass plate coated with silica gel G.
  Solvent system 
used was ethyl acetate: n-hexane (9:1).  The IR spectra of the 
compounds  were  recorded  using  KBr  pellets  on  Fourier 
Transform Infrared Spectrophotometer (FTIR-Shimadzu) 
1H-
NMR spectrum were recorded using  Bruker spectrometer at 
DPX-300 MHz using TMS  as internal standard (Chemical 
shifts in ppm). DMSO-d6 was used as solvent. 
Synthesis of 2-phenyl-1, 3-benzoxazole and substituted 2-
phenyl-1, 3-benzoxazoles: 
A  dry  vial  charged  with  1.8  mmol  (0.196g)  of  o-
aminophenol, 2.0 mmol of acyl chloride in 2.5ml of dioxan 
was  placed  in  microwave  synthesizer  (CEM-Labmet)  and 
irradiated at 150 W for 15 min while the temperature was set 
to 160
o C. The extent of the reaction was monitored by silica 
gel G coated TLC plates. After the reaction was completed, 
the reaction mixture was cooled and transferred to a stirred 
solution of 1N NaOH (50ml). The precipitate obtained was 
filtered,  washed  with  water,  dried  and  recrystallized  from 
methanol. The yield and melting points are listed in Table-1. 
2-phenyl-1,  3-benzoxazole  (1a):    0.26g  (73.42%),  light 
yellow, m.p. 102-104
oC.  
IR  (KBr):  3134(Ar  C-H  str.),  1553(C=N  str.),  1241(C-O 
str.)cm
-1 
1H-NMR (DMSO) δ (ppm): 7.362-8.246 (Ar-H, 9H). 
2-(2-methoxyphenyl)-1,  3-benzoxazole  (1b):0.26g 
(65.12%), beige, m.p. 54-56
oC.  
IR  (KBr):  3174(Ar  C-H  str.),  1593
  (C=N  str.),  1244(C-O 
str.)cm
-1 
1H-NMR  (DMSO)  δ  (ppm):7.401-8.148  (Ar-H,  8H), 
3.327(3H). 
 2-(3-methoxyphenyl)-1, 3-benzoxazole (1c): 0.39g (98%), 
Dark yellow, m.p. 70-73
oC. 
IR  (KBr):  3172(Ar  C-H  str.),  1607
  (C=N  str.),  1226(C-O 
str.)cm
-1. 
1H-NMR  (DMSO)  δ  (ppm):7.378-8.219  (Ar-H,  8H), 
3.377(3H). 
2-(2-bromophenyl)-1,  3-benzoxazole  (1d):  0.31g  (63.2%), 
yellow, m.p. 53-56
oC  
IR (KBr): 3150(Ar C-H str.), 1546
 (C=N str.), 1256(C-O str.), 
594(C-Br str.)cm
-1 
1H-NMR (DMSO) δ (ppm):7.477-8.455 (Ar-H, 8H). 
2-(3-bromophenyl)-1,  3-benzoxazole  (1e):  0.27g  (54.6%), 
beige, m.p.128-130
oC  
IR (KBr): 1591
 (C=N str.), 1289(C-O str.), 598(C-Br str.)cm
-1 
1H-NMR (DMSO) δ(ppm):7.066-7.186 (Ar-H, 8H).
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2-(4-bromophenyl)-1,  3-benzoxazole  (1f):  0.41g  (83.2%), 
white, m.p. 155-156
oC  
IR (KBr): 1588
 (C=N str.), 1287(C-O str.), 604(C-Br str.)cm
-1 
1H-NMR (DMSO) δ (ppm):7.449-8.110 (Ar-H, 8H).  
2-(3-chlorophenyl)-1,  3-benzoxazole  (1g):0.28g  (68%), 
yellow, m.p.131-133
oC  
IR (KBr): 3123(Ar C-H str.), 1607
 (C=N str.), 1207(C-O str.), 
745(C-Cl str.)cm
-1 
1H-NMR (DMSO) δ (ppm):7.421-8.825 (Ar-H, 8H). 
2-(4-chlorophenyl)-1,  3-benzoxazole  (1h):0.35g  (83.7%), 
light yellow, m.p.148-149
oC.  
IR (KBr): 3150(Ar C-H str.), 1549(C=N str.), 1230(C-O str.), 
742(C-Cl str.)cm
-1 
1H-NMR (DMSO) δ (ppm):7.417-8.312 (m, Ar-H, 8H). 
2-(2-nitrophenyl)-1, 3-benzoxazole (1i):0.24g (56.6%), pale 
yellow, m.p.101-103
oC  
IR  (KBr):    3160(Ar  C-H  str.),  1550(C=N  str.),  1241(C-O 
str.), 1550(C-NO2) cm
-1 
1H-NMR (DMSO) δ (ppm):7.415-8.159 (Ar-H, 8H). 
2-(3-nitrophenyl)-1, 3-benzoxazole (1j):0.25g (57.8%), pale 
yellow, m.p.211-212
oC  
IR  (KBr):    3090(Ar  C-H  str.),  1589(C=N  str.),  1248(C-O 
str.), 1506(C-NO2) cm
-1 
1H-NMR (DMSO) δ (ppm):7.199-7.850 (Ar-H, 8H). 
2-(4-nitrophenyl)-1,  3-benzoxazole  (1k):0.37g  (85.6%), 
yellow, m.p. 266-268
oC  
IR  (KBr):    3215(Ar  C-H  str.),  1588(C=N  str.),  1226(C-O 
str.), 1539(C-NO2) cm
-1 
1H-NMR (DMSO) δ (ppm):7.450-8.237 (Ar-H, 8H). 
2-(2,3,4,5,6-pentafluorophenyl)-1,3-benzoxazole  (1l): 
0.33g (68.9%), yellow, m.p.113-115
oC  
IR (KBr): 1576(C=N str.), 1302(C-O str.), 997(C-F)cm
-1 
1H-NMR (DMSO) δ (ppm):7.488-7.970 (Ar-H, 4H). 
Antimicrobial activity
14 
The  synthesized  compounds  were  evaluated  for  the  invitro 
antibacterial activity against Gram-positive bacteria: Bacillus 
pumilus,  Bacillus  subtilis.  Gram-negative  bacteria: 
Escherichia coli, Pseudomonas aeruginosa. The compound 
was  also  tested  for  the  in-vitro  antifungal  activity  against 
Candida  albicans  and  Aspergillus  niger  by  agar-well 
diffusion  method  at  2.5mg/ml,  5mg/ml  and  10mg/ml 
concentration of test compounds. Ciprofloxacin was used as 
the standard 
antibacterial agent whereas Fluconazole was used as standard 
antifungal agent. The diameter of the zone of inhibition was 
measured and recorded in Table-3 and 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1 Scheme of synthesis of compounds (1a-1l) 
 
 
Table-1 Yield and melting point data of the synthesized compounds 
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S.No.  Compound  Name of compound  R1’  R2’  R3’  R4’  R5’  Molecular 
formula 
Yield 
(%) 
m.p.(
oC) 
1  1a  2-pheny-1,3-benzoxazole  H  H  H  H  H  C13H9NO  83.42  102-104 
2  1b  2-(2-methoxyphenyl)-1,3-benzoxazole  OCH3  H  H  H  H  C14H11NO2 
 
65.12  54-56 
3  1c  2-(3-methoxyphenyl)-1,3-benzoxazole  H  OCH3  H  H  H  C14H11NO2 
 
98.00  70-73 
4  1d  2-(2-bromophenyl)-1,3-benzoxazole  Br  H  H  H  H  C13H8BrNO  63.21  53-56 
5  1e  2-(3-bromophenyl)-1,3-benzoxazole  H  Br  H  H  H  C13H8BrNO  54.60  128-130 
6  1f  2-(4-bromophenyl)-1,3-benzoxazole  H  H  Br  H  H  C13H8BrNO 
 
83.20  155-156 
7  1g  2-(3-cholorophenyl)-1,3-benzoxazole  H  Cl  H  H  H  C13H8ClNO 
 
68.00  131-133 
8  1h  2-(4-chlorophenyl)-1,3-benzoxazole  H  H  Cl  H  H  C13H8ClNO 
 
83.70  148-149 
9  1i  2-(2-nitrophenyl)-1,3-benzoxazole  NO2  H  H  H  H  C13H8N2O3  56.60  101-103 
10  1j  2-(3-nitrophenyl)-1,3-benzoxazole  H  NO2  H  H  H  C13H8N2O3  57.80  211-212 
11  1k  2-(4-nitrophenyl)-1,3-benzoxazole  H  H  NO2  H  H  C13H8N2O3 
 
85.60  266-268 
12  1l  2-(2,3,4.5.6pentafluorophenyl)-1,3-
benzoxazole 
F  F  F  F  F  C13H5F5NO  68.90  113-115 
 
Table-2 Antibactrial activity [Diameter of Zone of inhibition (mm)] 
COMPOUND  E.coli  P.aeruginosa  B.subtilis  B.pumilus 
C1  C2  C3  C1  C2  C3  C1  C2  C3  C1  C2  C3 
1a  0  0  10  0  10  8  0  14  0  12  12  0 
1b  0  18  12  0  16  12  10  14  10  0  14  10 
1c  0  12  10  0  14  12  12  14  12  0  10  12 
1d  10  10  0  11  16  0  0  10  12  0  10  0 
1e  0  14  0  10  16  12  0  16  16  0  14  0 
1f  11  14  8  14  16  10  10  18  12  0  18  12 
1g  0  12  8  0  16  0  0  16  14  0  10  16 
1h  10  12  12  11  10  10  0  10  12  0  14  12 
1i  14  18  14  12  18  14  0  20  12  0  12  12 
1j  0  12  0  12  12  12  0  10  9  0  14  16 
1k  8  10  10  0  9  8  12  11  0  12  10  0 
1l  12  12  10  10  10  0  0  8  0  0  8  0 
Std.  23  20  22  21 
DMSO  0  0  0  0  0  0  0  0  0  0  0  0 
 
Table-3 Antifungal activity [Diameter of Zone of inhibition (mm)] 
COMPOUND  C.albicans  A.niger 
C1  C2  C3  C1  C2  C3 
1a  0  10  8  0  0  0 
1b  12  18  13  12  14  10 
1c  0  16  0  0  12  12 
1d  8  10  18  6  10  0 
1e  6  12  1  14  14  12 
1f  8  16  12  8  16  10 
1g  12  12  0  0  14  12 
1h  0  12  14  10  10  12 
1i  0  8  0  0  10  8 
1j  8  12  11  0  11  10 
1k  10  12  0  0  0  0 
1l  0  6  0  10  8  0 
Std.  23  22 
DMSO  0  0  0  0  0  0 
 
C1:2.5mg/ml.                    NZ: No Zone. 
C2:5mg/ml.     Std.: Ciprofloxacin for bacteria 
C3:10mg/ml.                     Fluconazole for fungi. 
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Fig-1 Antibacterial activity 
 
Fig-2 Antifungal activity 
 
 
 
RESULTS 
A series of 2-phenyl-1, 3-benzoxazoles were synthesized by 
the  reaction  of  2-aminophenol  and  acyl  chlorides  using 
microwave  irradiation.  The  yields  of  the  synthesized 
compounds  are  given  in  Table  1.  Compounds  were 
synthesized in moderate to good yield. Purity of compounds 
was  determined  by  TLC  on  silica  gel  G  plates.  The  spots 
were  detected  by  exposure  to  iodine  vapours.  Synthesized 
compounds  were  characterized  by  spectral  analysis  (FTIR, 
1H-NMR). The spectra were found to be in agreement with 
the assigned molecular structures. 
DISCUSSION  
The  synthesized  compounds  (1a-1l)  were  evaluated  for  in 
vitro  antimicrobial  activity  by  agar-well  diffusion  method. 
C2(5mg/ml)  gave higher activity    than  C1(2.5mg/ml)   and 
C3(10mg/ml).Compounds  1b{2-(2-methoxyphenyl)-1,3-
benzoxazole},  1f  {2-(4-bromophenyl)-1,3-benzoxazole},  1g 
{2-(3-cholorophenyl)-1,3-benzoxazole},  1i  {2-(2-
nitrophenyl)-1,3-benzoxazole}  were    found  to  have  good 
antibacterial activity 
Compounds 1b {2-(2-methoxypheny)-1, 3-benzoxazole}, 1f 
{2-(4-bromophenyl)-1,  3-benzoxazole}  were  potent 
antifungal compounds amongst the series. (Fig-1 and 2) 
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